Gradalis is advancing cancer treatment with Vigil, a fully personalized immunotherapy that empowers a patient’s own immune system to identify and destroy cancer cells.
Vigil’s patient-specific approach has demonstrated success in research and clinical trial phases in treating ovarian cancer, with potential applications across other solid tumor types. Vigil can be used alone or in concert with other treatments.
Vigil is more than just innovation, it’s a new way forward, created just for you.
Vigil’s patient-specific approach has demonstrated success in research and clinical trial phases in treating ovarian cancer, with potential applications across other solid tumor types. Vigil can be used alone or in concert with other treatments.
Vigil is more than just innovation, it’s a new way forward, created just for you.
